PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Obstetrics & Gynecology Science10.5468/ogs.210672021644345-352Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?Eryn Sara Rubenfeld, Michael Haim Dahanhttp://ogscience.org/upload/pdf/ogs-21067.pdf, http://ogscience.org/journal/view.php?doi=10.5468/ogs.21067, http://ogscience.org/upload/pdf/ogs-21067.pdf
Fertility and Sterility10.1016/j.fertnstert.2020.08.28520201143e94DOES THE TIMING OF CABERGOLINE ADMINISTRATION IMPACT RATES OF OHSS?Eryn Sarah Rubenfeld, Daniel Dahan, Yehuda Dahan, Michael H. Dahanhttps://api.elsevier.com/content/article/PII:S0015028220310396?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0015028220310396?httpAccept=text/plain
Reproductive Medicine and Biology10.1007/s12522-014-0198-9201414279-84Cabergoline administration prevents development of moderate to severe ovarian hyperstimulation syndrome and it contributes to reduction in ovarian volumeTomoko Inoue, Shu Hashimoto, Hideyuki Iwahata, Keijiro Ito, Yoshiharu Nakaoka, Yoshiharu Morimotohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1007%2Fs12522-014-0198-9, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1007%2Fs12522-014-0198-9, https://onlinelibrary.wiley.com/doi/full/10.1007/s12522-014-0198-9
Obesity and metabolism10.14341/2071-8713-513020129448-50The use of cabergoline for treatment of syndrome of ovarian hyperstimulationS Yu Vorotnikovahttps://omet-endojournals.ru/omet/article/viewFile/5130/2948, https://omet-endojournals.ru/omet/article/viewFile/5130/2948
Reactions Weekly10.1007/s40278-021-99019-x20211864189-89Cabergoline/chorionic gonadotropin/leuprorelinhttps://link.springer.com/content/pdf/10.1007/s40278-021-99019-x.pdf, https://link.springer.com/article/10.1007/s40278-021-99019-x/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-021-99019-x.pdf
Ovarian Hyperstimulation Syndrome10.1017/cbo9780511547294.005200143-78Pathophysiology of Ovarian Hyperstimulation Syndromehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/AA486E56ECDBA0F132228EE0635072B1
Ovarian Hyperstimulation Syndrome10.1017/cbo9780511547294.0102001200-226Treatment of Ovarian Hyperstimulation Syndromehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/6479685187FED5824B8A9DCCC815BC00
Ovarian Hyperstimulation Syndrome10.1017/cbo9780511547294.0092001130-199Prevention of Ovarian Hyperstimulation Syndromehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/52C55ECF5E3E91497B6116CB41A5217E
Ovarian Hyperstimulation Syndrome10.1017/cbo9780511547294.00320011-9Classification of Ovarian Hyperstimulation Syndromehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/CFE84F551158FCE8F873694E7E160FAB
Ovarian Hyperstimulation Syndrome10.1017/cbo9780511547294.0082001119-129Prediction of Ovarian Hyperstimulation Syndromehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/0750E72B48D3499D87F8BF7D00CC656D